Article
Characterization of KRAS rearrangements in metastatic prostate cancer.
Cancer discovery - 1 Jun 2011
Wang Xiao-Song, Shankar Sunita, Dhanasekaran Saravana M, Ateeq Bushra, Sasaki Atsuo T, Jing Xiaojun, Robinson Daniel, Cao Qi, Prensner John R, Yocum Anastasia K, Wang Rui, Fries Daniel F, Han Bo, Asangani Irfan A, Cao Xuhong, Li Yong, Omenn Gilbert S, Pflueger Dorothee, Gopalan Anuradha, Reuter Victor E, Kahoud Emily Rose, Cantley Lewis C, Rubin Mark A, Palanisamy Nallasivam, Varambally Sooryanarayana, Chinnaiyan Arul M
Abstract excerpt
UNLABELLED: Using an integrative genomics approach called amplification breakpoint ranking and assembly analysis, we nominated KRAS as a gene fusion with the ubiquitin-conjugating enzyme UBE2L3 in the DU145 cell line, originally derived from prostate cancer metastasis to the brain. Interestingly, analysis of tissues revealed that 2 of 62 metastatic prostate cancers harbored aberrations at the KRAS locus. In DU145...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
